New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
17:09 EDTLEE, MDLZ, JNJBerkshire Hathaway reports decreased stakes in Mondelez, J&J, Lee Enterprises
News For MDLZ;JNJ;LEE From The Last 14 Days
Check below for free stories on MDLZ;JNJ;LEE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 15, 2014
09:16 EDTJNJOn The Fly: Pre-market Movers
Subscribe for More Information
09:11 EDTJNJJohnson & Johnson says has implemented some cost reductions in MD&D sector
Says has implemented some cost reductions, combined some businesses in the Medical Devices & Diagnostics sector to better compete in the current marketplace.
08:56 EDTJNJJohnson & Johnson sees FY net interest expense $400M-$500M
Subscribe for More Information
08:19 EDTJNJJohnson & Johnson sees deal to sell K-Y brand to Reckitt closing mid-year
Sees sees deal to sell K-Y brand to Reckitt Benckiser (RBGPF) closing mid-year. Says offer from Carlyle Group (CG) to acquire Ortho-Clinical Diagnostics expected to close mid-year. Comments from slides that will be presented on the Q1 earnings conference call.
07:49 EDTJNJJohnson & Johnson reports Q1 Domestic sales up 2.2%; Intl sales up 4.5%
Subscribe for More Information
07:47 EDTJNJJohnson & Johnson raises FY14 EPS to $5.80-$5.90, consensus $5.83
Subscribe for More Information
07:46 EDTJNJJohnson & Johnson reports Q1 adjusted EPS $1.54, consensus $1.48
Reports Q1 revenue $18.1B, consensus $18.0B
06:32 EDTJNJPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
April 14, 2014
15:17 EDTJNJNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $1.48; Coca-Cola (KO), consensus 44c; Charles Schwab (SCHW), consensus 22c; Northern Trust (NTRS), consensus 78c; Comerica (CMA), consensus 72c; Westamerica (WABC), consensus 58c; Comverse (CNSI), consensus 49c; Pep Boys (PBY), consensus 5c.
13:25 EDTJNJEarnings Preview: J&J looking for another strong performance in pharmaceuticals
Subscribe for More Information
10:02 EDTJNJOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:56 EDTJNJJohnson & Johnson downgraded to Hold from Buy at Jefferies
Jefferies downgraded its rating on Johnson & Johnson (JNJ) to Hold citing the recent outperformance of shares. The firm keeps a $105 price target for the stock.
April 11, 2014
18:44 EDTJNJJ&J halting development of Botox competitor, WSJ says
Subscribe for More Information
April 10, 2014
07:31 EDTMDLZMondelez spends $110M on new Russia factory, Bloomberg says
Mondelez is planning to spend $110M on a new plant in Russia, which will add enough capacity to make 50K tons of snacks annually, according to Bloomberg, citing comments from company spokesman Michael Mitchell. The new factory is projected to create 180 jobs. Reference Link
April 9, 2014
13:35 EDTMDLZHershey melts after Goldman downgrade
Shares of chocolate maker Hershey (HSY) are falling after Goldman Sachs lowered its rating on the stock to a Sell. WHAT'S NEW: After the market closed last night, Goldman Sachs downgraded Hershey to Sell from Neutral, saying the stock is "priced for perfection" and that the company's cycle of strong earnings growth will end. Goldman lowered its price target for the stock to $90 from $105. Goldman Sachs analysts Jason English, Sean King and Manpreet Sethl were cautious on Hershey, saying that they expect the company's domestic momentum to fade. Goldman lowered its earnings per share estimates for Hershey's fiscal years 2014 through 2016 by 3%-6% to reflect lower sales and margin projections. While they said that they still perceive Hershey as a "best-in-breed company" whose international momentum will continue, the analysts believe expectations for the company are on the verge of turning more negative. OTHERS TO WATCH: Other companies in the chocolate industry include Nestle (NSRGY) and Mondelez (MDLZ), which owns Cadbury. PRICE ACTION: During afternoon trading, shares of Hershey fell $2.57 or $2.53%, to $99.15.
10:06 EDTMDLZOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:23 EDTJNJEuropean Association for the Study of the Liver to hold annual meeting
Subscribe for More Information
07:09 EDTJNJJohnson & Johnson outlook positive into Q1 results, says Bernstein
Bernstein expects Johnson & Johnson's Q1 EPS to come in slightly above the consensus estimate, with strength in pharmaceuticals more than offsetting lackluster Medical Devices & Diagnostics growth, according to the firm. Bernstein keeps an Outperform rating on the stock.
April 8, 2014
16:07 EDTMDLZMondelez initiated with a Reduce at Nomura
Target $31.
07:26 EDTJNJElsevier Business Intelligence to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use